{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220907",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "72047",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761127Orig1s000ltr.pdf",
              "date": "20220908",
              "type": "Letter"
            },
            {
              "id": "72050",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761127s000lbl.pdf",
              "date": "20220909",
              "type": "Label"
            },
            {
              "id": "72258",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/761127Orig1s000TOC.html",
              "date": "20221006",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20230811",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "75061",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761127Orig1s002ltr.pdf",
              "date": "20230814",
              "type": "Letter"
            },
            {
              "id": "75080",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761127s002lbl.pdf",
              "date": "20230816",
              "type": "Label"
            },
            {
              "id": "75081",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761127s002lbl.pdf#page=16",
              "date": "20230816",
              "type": "Medication Guide"
            }
          ]
        }
      ],
      "application_number": "BLA761127",
      "sponsor_name": "REVANCE THERAPEUTICS, INC.",
      "openfda": {
        "application_number": [
          "BLA761127"
        ],
        "brand_name": [
          "DAXXIFY"
        ],
        "generic_name": [
          "BOTULINUM TOXIN TYPE A"
        ],
        "manufacturer_name": [
          "Revance Therapeutics, Inc."
        ],
        "product_ndc": [
          "72960-112"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR"
        ],
        "substance_name": [
          "BOTULINUM TOXIN TYPE A"
        ],
        "rxcui": [
          "2612454",
          "2612456"
        ],
        "spl_id": [
          "71c76e28-0eb6-487e-a53b-4c9e78021e57"
        ],
        "spl_set_id": [
          "3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74"
        ],
        "package_ndc": [
          "72960-112-01",
          "72960-112-02",
          "72960-112-05",
          "72960-112-06"
        ],
        "nui": [
          "N0000175771",
          "N0000193962",
          "N0000175731",
          "N0000175770"
        ],
        "pharm_class_epc": [
          "Acetylcholine Release Inhibitor [EPC]",
          "Neuromuscular Blocker [EPC]"
        ],
        "pharm_class_pe": [
          "Neuromuscular Blockade [PE]"
        ],
        "pharm_class_moa": [
          "Acetylcholine Release Inhibitors [MoA]"
        ],
        "unii": [
          "E211KPY694"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "DAXXIFY",
          "active_ingredients": [
            {
              "name": "DAXIBOTULINUMTOXINA-LANM",
              "strength": "0.1ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INTRAMUSCULAR, SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}